SKI Market

Indian Indices

Nifty

24,718.60 -169.60
(-0.68%)

Sensex

81,118.60 -573.38
( -0.70%)

Bank Nifty

55,527.35 -555.20
( -0.99%)

Nifty IT

38,469.25 8.95
( 0.02%)

Global Indices

Nasdaq

42,214.73 -773.90
(-1.80%)

Dow Jones

5,997.34 -68.92
(-1.14%)

Hang Seng

37,801.43 -371.66
(-0.97%)

Nikkei 225

8,850.63 -34.29
(-0.39%)

Forex

USD-INR

85.55 0.07
(0.08%)

EUR-INR

98.89 0.98
(1.00%)

GBP-INR

116.24 0.70
(0.61%)

JPY-INR

0.60 0.01
(0.86%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Neuland Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524558

INE794A01010

1182.3025039

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NEULANDLAB

83.76

16923.01

EPS(TTM)

Face Value()

Div & Yield %

157.47

0.09

Back

ag ventures ltd

Croissance reports consolidated net loss of Rs 0.27 crore in the December 2024 quarter

Feb 06,2025

Net loss of Croissance reported to Rs 0.27 crore in the quarter ended December 2024 as against net profit of Rs 0.03 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 as against Rs 0.06 crore during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	0	0.06	-100
OPM %	0	50.00	-
PBDT	-0.27	0.03	PL
PBT	-0.27	0.03	PL
NP	-0.27	0.03	PL

24,718.60 -169.60 (-0.68%)

81,118.60 -573.38 ( -0.70%)

55,527.35 -555.20 ( -0.99%)

38,469.25 8.95 ( 0.02%)

42,214.73 -773.90 (-1.80%)

5,997.34 -68.92 (-1.14%)

37,801.43 -371.66 (-0.97%)

8,850.63 -34.29 (-0.39%)

85.55 0.07 (0.08%)

98.89 0.98 (1.00%)

116.24 0.70 (0.61%)

0.60 0.01 (0.86%)